News Focus
News Focus
Followers 269
Posts 18920
Boards Moderated 0
Alias Born 01/19/2006

Re: Chromosome post# 427702

Saturday, 08/03/2024 8:46:34 PM

Saturday, August 03, 2024 8:46:34 PM

Post# of 448129
Yes. I thought a buy out at a price exceeding $3/share would give me a substantial IRA LTCL in those shares I sold. I started with only 1000 shares I had purchased in my IRA at a price under $1/share.

BTW, there is quite a discussion on the MRK and Biotech Value boards concerning what MRK may/should be contemplating vis a vis purchasing VKTX with its weight loss drug portfolio to offset its potential revenue loss stemming from Keytruda patent expiration in 2027-8.

I was prescribed Vascepa taken with MRK’s simvastatin(Zocor) in 2013 as a T1-diabetic, and have since lost weight from about 180 lbs to present 150 lbs, my teen age weight. I have experienced no adverse CVD events while reducing the amounts of LLY’s Humulin and Humalog I take each day by ~ 40%. IMO, MRK should be considering a buyout of Amarin, whatever it does wrt VKTX.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News